| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |